Cargando…
Efficacy of chemotherapeutics on classic and non-classic Kaposi sarcoma: a single-center retrospective real-world study
Kaposi sarcoma (KS) is a rare disease, and especially for classic KS, a gap exists in the literature about which chemotherapeutics should be given. Here we present our institutional data on the demographic characteristics, treatment, and treatment efficacy in 16 patients with KS treated with chemoth...
Autores principales: | Orhan, Sibel Oyucu, Şahin, Ahmet Bilgehan, Çubukçu, Erdem, Deligönül, Adem, Ocak, Birol, Orhan, Bedrettin, Evrensel, Türkkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554703/ https://www.ncbi.nlm.nih.gov/pubmed/33596402 http://dx.doi.org/10.17305/bjbms.2020.5329 |
Ejemplares similares
-
The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
por: Deligönül, Adem, et al.
Publicado: (2021) -
Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
por: Şahin, Ahmet Bilgehan, et al.
Publicado: (2021) -
The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer
por: Ocak, Birol, et al.
Publicado: (2021) -
Classic Kaposi Sarcoma: to treat or not to treat?
por: Vincenzi, Bruno, et al.
Publicado: (2015) -
Classic Kaposi's sarcoma in Italy, 1985–1998
por: Dal Maso, L, et al.
Publicado: (2005)